Corteva Announces Dates for First Quarter 2024 Earnings Release and Webcast
Corteva Announces Dates for First Quarter 2024 Earnings Release and Webcast
PR Newswire
INDIANAPOLIS, March 13, 2024
INDIANAPOLIS, March 13, 2024 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it will release its first quarter 2024 earnings on Wednesday, May 1, 2024, after the stock market close via press release and its website. The earnings will be presented in a live webcast on Thursday, May 2, 2024, at 9:00 a.m. Eastern Time.
The slide presentation that accompanies the webcast will be posted on the Company's Investor Events and Presentations page. A replay of the webcast will also be available on the Investor Events and Presentations page until May 2, 2025.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the Company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/corteva-announces-dates-for-first-quarter-2024-earnings-release-and-webcast-302087132.html
SOURCE Corteva, Inc.
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth